Characterization of the bispecific VHH antibody gefurulimab (ALXN1720) targeting complement component 5, and designed for low volume subcutaneous administration
针对补体成分 5 的双特异性 VHH 抗体吉夫鲁利单抗 (ALXN1720) 的表征，设计用于小剂量皮下给药
期刊:Molecular Immunology
影响因子:3.2
doi:10.1016/j.molimm.2023.12.004
Siddharth Jindal, Dennis Vestergaard Pedersen, Nimish Gera, Julian Chandler, Rekha Patel, Alyssa Neill, Josh Cone, Yuchun Zhang, Chao-Xing Yuan, Ellen E Millman, Dan Carlin, Bridget Puffer, Douglas Sheridan, Gregers Rom Andersen, Paul Tamburini
